Concepedia

Helen Stacey

HS

4

Publications

236

Citations

4

H-Index

2018

Active since

Affiliations

Diablo Clinical Research(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Foothill Family Clinic

Helen Stacey is an author at Diablo Clinical Research specializing in liver physiology, autoimmune disease, and medicine.

ORCID

Top concepts

Publications per year

2018–2024

4

Publications

4

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Helen Stacey, Jeffrey B. Rosen, James T. Peterson et al. · Human Vaccines & Immunotherapeutics · 2019 · 108 citations · Full text

Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial

Joseph A. Murray, Dina Wassaf, Karen Dunn et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 54 citations

, , +14

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

James T. Peterson, Helen Stacey, John E. MacNair et al. · Human Vaccines & Immunotherapeutics · 2018 · 49 citations · Full text

A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6)

Paul T. Scott, Miwa Haranaka, Jung‐Hyun Choi et al. · Clinical Infectious Diseases · 2024 · 25 citations · Full text

Rows per page

1–4 of 4